Phase 3 Clinical Data on Vosorotide for Achondroplasia Presented at ASBMR Annual Meeting
source: pixabay.com

Phase 3 Clinical Data on Vosorotide for Achondroplasia Presented at ASBMR Annual Meeting

Last week, biotechnology company BioMarin announced that Dr. Lynda Polgreen, MD, MS would present at the American Society for Bone and Mineral Research (ASBMR) Annual 2020 Meeting. Her presentation centered…

Continue Reading Phase 3 Clinical Data on Vosorotide for Achondroplasia Presented at ASBMR Annual Meeting
European Commission Grants Orphan Designation Designation for Investigative Achondroplasia Therapy
source: pixabay.com

European Commission Grants Orphan Designation Designation for Investigative Achondroplasia Therapy

Ascendis Pharma has just announced that their investigative therapy for achondroplasia called TransCon CNP has just received Orphan Drug Designation from the European Commission. This same designation has already been…

Continue Reading European Commission Grants Orphan Designation Designation for Investigative Achondroplasia Therapy

“She’s a Happy Baby Since We’ve Been Home”: This Baby Born With Thanatophoric Dysplasia Finally Made It Home

As originally reported in Live 99.9; when Melissa and Chris Courson found out the baby they were expecting in a few months would be born with the rare thantophoric dysplasia,…

Continue Reading “She’s a Happy Baby Since We’ve Been Home”: This Baby Born With Thanatophoric Dysplasia Finally Made It Home

Little People of America’s 2019 National Conference

  • Post author:
  • Post category:

The 2019 LPA 62nd Annual National Conference San Francisco, California The Little People of America's annual conference is the ultimate experience for people affected by dwarfism and diastrophic dysplasia. This…

Continue Reading Little People of America’s 2019 National Conference